APO Research
Talk to an analyst

APO RESEARCH · REPORT

Metabotropic Glutamate Receptor 5

Compare research editions
View pricing & licenses

Selected research

Market Structure

Global Metabotropic Glutamate Receptor 5 Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032

22 December 2025190 pages

Choose your research edition.

Industry ResearchMetabotropic Glutamate Receptor 5 Industry Research Report 2026125 pages · $2,950 USDIndustry Growth & TrendsGlobal Metabotropic Glutamate Receptor 5 Industry Growth and Trends Forecast to 2032102 pages · $3,450 USDMarket StructureGlobal Metabotropic Glutamate Receptor 5 Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032190 pages · $3,950 USDMarket Outlook & Growth OpportunitiesGlobal Metabotropic Glutamate Receptor 5 Market Outlook and Growth Opportunities 2026190 pages · $4,250 USDMarket Analysis & ForecastGlobal Metabotropic Glutamate Receptor 5 Market Analysis and Forecast 2026-2032190 pages · $4,950 USD

Market perspective

The global Metabotropic Glutamate Receptor 5 market is projected to grow from US$ million in 2026 to US$ million by 2032, implying a CAGR of % over 2026-2032.

The US & Canada market for Metabotropic Glutamate Receptor 5 is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

The Europe market for Metabotropic Glutamate Receptor 5 is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

Read the full market overview

The Asia Pacific market for Metabotropic Glutamate Receptor 5 is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

The China market for Metabotropic Glutamate Receptor 5 is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

Leading global manufacturers of Metabotropic Glutamate Receptor 5 include Addex Therapeutics Ltd, Aevi Genomic Medicine Inc, Bristol-Myers Squibb Company, Heptares Therapeutics Ltd, Merz Pharma GmbH & Co KgaA, Richter Gedeon Nyrt, Sumitomo Dainippon Pharma Co Ltd, Toray Industries Inc and Eli Lilly and Company, among others. In 2025, the top three vendors together accounted for approximately % of global revenue.

This report provides an overview of the global Metabotropic Glutamate Receptor 5 market in terms of sales, revenue, and price, analyzing global market trends using historical revenue and sales data for 2021-2025, estimates for 2026, and projected CAGRs through 2032.

The study covers key producers of Metabotropic Glutamate Receptor 5 and sales in major regions and countries, assesses future market potential, and highlights priority regions and countries for segmenting the market into sub-sectors, with country-specific market value data for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, the Middle East, Africa, and other countries.

The report also presents Metabotropic Glutamate Receptor 5 sales, revenue, market share, and industry ranking for the main manufacturers for 2021-2026, identifies the major stakeholders in the global market, and analyzes their competitive landscape and market positioning based on recent developments and segmental revenues.

In addition, the report analyzes segment data by Type and Application—covering sales, revenue, and price—for 2021-2032, and evaluates and forecasts the Metabotropic Glutamate Receptor 5 market size, projected growth trends, production technologies, key applications, and end-use industries.

Metabotropic Glutamate Receptor 5 Segment by Company

Addex Therapeutics Ltd

Aevi Genomic Medicine Inc

Bristol-Myers Squibb Company

Heptares Therapeutics Ltd

Merz Pharma GmbH & Co KgaA

Richter Gedeon Nyrt

Sumitomo Dainippon Pharma Co Ltd

Toray Industries Inc

Eli Lilly and Company

Novartis AG

Johnson & Johnson

Eisai Co Ltd

Metabotropic Glutamate Receptor 5 Segment by Type

Alloswitch-1

BMS-952048

BMS-955829

Dipraglurant ER

Others

Metabotropic Glutamate Receptor 5 Segment by Application

Major Depressive Disorder

Alcohol Addiction

Alzheimer's Disease

Others

Metabotropic Glutamate Receptor 5 Segment by Region

North America

United States

Canada

Mexico

Europe

Germany

France

U.K.

Italy

Russia

Spain

Netherlands

Switzerland

Sweden

Poland

Asia-Pacific

China

Japan

South Korea

India

Australia

Taiwan

Southeast Asia

South America

Brazil

Argentina

Chile

Middle East & Africa

Egypt

South Africa

Israel

Türkiye

GCC Countries

Study Objectives

1. To analyze and research the global status and future forecast, involving, production, value, consumption, growth rate (CAGR), market share, historical and forecast.

2. To present the key manufacturers, capacity, production, revenue, market share, and Recent Developments.

3. To split the breakdown data by regions, type, manufacturers, and Application.

4. To analyze the global and key regions market potential and advantage, opportunity and challenge, restraints, and risks.

5. To identify significant trends, drivers, influence factors in global and regions.

6. To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.

Reasons to Buy This Report

1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Metabotropic Glutamate Receptor 5 market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.

2. This report will help stakeholders to understand the global industry status and trends of Metabotropic Glutamate Receptor 5 and provides them with information on key market drivers, restraints, challenges, and opportunities.

3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in volume and value), competitor ecosystem, new product development, expansion, and acquisition.

4. This report stays updated with novel technology integration, features, and the latest developments in the market.

5. This report helps stakeholders to gain insights into which regions to target globally.

6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Metabotropic Glutamate Receptor 5.

7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

Chapter 1: Provides an overview of the Metabotropic Glutamate Receptor 5 market, including product definition, global market growth prospects, market size, sales, and average price forecasts (2021-2032).

Chapter 2: Provides the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.

Chapter 3: Detailed analysis of Metabotropic Glutamate Receptor 5 manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, etc.

Chapter 4: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.

Chapter 5: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.

Chapter 6: Sales of Metabotropic Glutamate Receptor 5 in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space of each country in the world.

Chapter 7: Revenue of Metabotropic Glutamate Receptor 5 in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space of each country in the world.

Chapter 8: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.

Chapter 9: Analysis of industrial chain, including the upstream and downstream of the industry.

Chapter 10: Concluding Insights of the report

More report detail

Tables and figures
List of Tables Table 1. Metabotropic Glutamate Receptor 5 Industry Trends Table 2. Metabotropic Glutamate Receptor 5 Industry Drivers Table 3. Metabotropic Glutamate Receptor 5 Industry Opportunities and Challenges Table 4. Metabotropic Glutamate Receptor 5 Industry Restraints Table 5. Global Metabotropic Glutamate Receptor 5 Revenue by Manufacturers (US$ Million) & (2021-2026) Table 6. Global Metabotropic Glutamate Receptor 5 Revenue Market Share by Manufacturers (2021-2026) Table 7. Global Metabotropic Glutamate Receptor 5 Sales by Manufacturers (k units) & (2021-2026) Table 8. Global Metabotropic Glutamate Receptor 5 Sales Market Share by Manufacturers Table 9. Global Metabotropic Glutamate Receptor 5 Average Sales Price (US$/unit) of Manufacturers (2021-2026) Table 10. Global Metabotropic Glutamate Receptor 5 Industry Manufacturers Ranking, 2024 VS 2025 VS 2026 Table 11. Global Metabotropic Glutamate Receptor 5 Key Manufacturers Manufacturing Sites & Headquarters Table 12. Global Metabotropic Glutamate Receptor 5 Manufacturers, Product Type & Application Table 13. Global Metabotropic Glutamate Receptor 5 Manufacturers Establishment Date Table 14. Global Manufacturers Market Concentration Ratio (CR5 and HHI) Table 15. Global Metabotropic Glutamate Receptor 5 by Manufacturers Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue of 2025) Table 16. Major Manufacturers of Alloswitch-1 Table 17. Major Manufacturers of BMS-952048 Table 18. Major Manufacturers of BMS-955829 Table 19. Major Manufacturers of Dipraglurant ER Table 20. Major Manufacturers of Others Table 21. Global Metabotropic Glutamate Receptor 5 Sales by Type 2021 VS 2025 VS 2032 (k units) Table 22. Global Metabotropic Glutamate Receptor 5 Sales by Type (2021-2026) & (k units) Table 23. Global Metabotropic Glutamate Receptor 5 Sales by Type (2027-2032) & (k units) Table 24. Global Metabotropic Glutamate Receptor 5 Sales Market Share by Type (2021-2026) Table 25. Global Metabotropic Glutamate Receptor 5 Sales Market Share by Type (2027-2032) Table 26. Global Metabotropic Glutamate Receptor 5 Revenue by Type 2021 VS 2025 VS 2032 (k units) Table 27. Global Metabotropic Glutamate Receptor 5 Revenue by Type (2021-2026) & (k units) Table 28. Global Metabotropic Glutamate Receptor 5 Revenue by Type (2027-2032) & (k units) Table 29. Global Metabotropic Glutamate Receptor 5 Revenue Market Share by Type (2021-2026) Table 30. Global Metabotropic Glutamate Receptor 5 Revenue Market Share by Type (2027-2032) Table 31. Major Manufacturers of Major Depressive Disorder Table 32. Major Manufacturers of Alcohol Addiction Table 33. Major Manufacturers of Alzheimer's Disease Table 34. Major Manufacturers of Others Table 35. Global Metabotropic Glutamate Receptor 5 Sales by Application 2021 VS 2025 VS 2032 (k units) Table 36. Global Metabotropic Glutamate Receptor 5 Sales by Application (2021-2026) & (k units) Table 37. Global Metabotropic Glutamate Receptor 5 Sales by Application (2027-2032) & (k units) Table 38. Global Metabotropic Glutamate Receptor 5 Sales Market Share by Application (2021-2026) Table 39. Global Metabotropic Glutamate Receptor 5 Sales Market Share by Application (2027-2032) Table 40. Global Metabotropic Glutamate Receptor 5 Revenue by Application 2021 VS 2025 VS 2032 (k units) Table 41. Global Metabotropic Glutamate Receptor 5 Revenue by Application (2021-2026) & (k units) Table 42. Global Metabotropic Glutamate Receptor 5 Revenue by Application (2027-2032) & (k units) Table 43. Global Metabotropic Glutamate Receptor 5 Revenue Market Share by Application (2021-2026) Table 44. Global Metabotropic Glutamate Receptor 5 Revenue Market Share by Application (2027-2032) Table 45. Global Metabotropic Glutamate Receptor 5 Sales by Region: 2021 VS 2025 VS 2032 (k units) Table 46. Global Metabotropic Glutamate Receptor 5 Sales by Region (2021-2026) & (k units) Table 47. Global Metabotropic Glutamate Receptor 5 Sales Market Share by Region (2021-2026) Table 48. Global Metabotropic Glutamate Receptor 5 Sales Forecasted by Region (2027-2032) & (k units) Table 49. Global Metabotropic Glutamate Receptor 5 Sales Forecasted Market Share by Region (2027-2032) Table 50. North America Metabotropic Glutamate Receptor 5 Sales Growth Rate by Country: 2021 VS 2025 VS 2032 (k units) Table 51. North America Metabotropic Glutamate Receptor 5 Sales by Country (2021-2026) & (k units) Table 52. North America Metabotropic Glutamate Receptor 5 Sales by Country (2027-2032) & (k units) Table 53. Europe Metabotropic Glutamate Receptor 5 Sales Growth Rate by Country: 2021 VS 2025 VS 2032 (k units) Table 54. Europe Metabotropic Glutamate Receptor 5 Sales by Country (2021-2026) & (k units) Table 55. Europe Metabotropic Glutamate Receptor 5 Sales by Country (2027-2032) & (k units) Table 56. Asia Pacific Metabotropic Glutamate Receptor 5 Sales Growth Rate by Country: 2021 VS 2025 VS 2032 (k units) Table 57. Asia Pacific Metabotropic Glutamate Receptor 5 Sales by Country (2021-2026) & (k units) Table 58. Asia Pacific Metabotropic Glutamate Receptor 5 Sales by Country (2027-2032) & (k units) Table 59. South America, Middle East and Africa Metabotropic Glutamate Receptor 5 Sales Growth Rate by Country: 2021 VS 2025 VS 2032 (k units) Table 60. South America, Middle East and Africa Metabotropic Glutamate Receptor 5 Sales by Country (2021-2026) & (k units) Table 61. South America, Middle East and Africa Metabotropic Glutamate Receptor 5 Sales by Country (2027-2032) & (k units) Table 62. Global Metabotropic Glutamate Receptor 5 Revenue Grow Rate (CAGR) by Region: 2021 VS 2025 VS 2032 (US$ Million) Table 63. Global Metabotropic Glutamate Receptor 5 Revenue by Region (2021-2026) & (US$ Million) Table 64. Global Metabotropic Glutamate Receptor 5 Revenue by Region (2027-2032) & (US$ Million) Table 65. Global Metabotropic Glutamate Receptor 5 Revenue Market Share by Region (2021-2026) Table 66. Global Metabotropic Glutamate Receptor 5 Revenue Market Share by Region (2027-2032) Table 67. Addex Therapeutics Ltd Company Information Table 68. Addex Therapeutics Ltd Business Overview Table 69. Addex Therapeutics Ltd Metabotropic Glutamate Receptor 5 Sales (k units), Price (US$/unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 70. Addex Therapeutics Ltd Metabotropic Glutamate Receptor 5 Product Portfolio Table 71. Addex Therapeutics Ltd Recent Development Table 72. Aevi Genomic Medicine Inc Company Information Table 73. Aevi Genomic Medicine Inc Business Overview Table 74. Aevi Genomic Medicine Inc Metabotropic Glutamate Receptor 5 Sales (k units), Price (US$/unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 75. Aevi Genomic Medicine Inc Metabotropic Glutamate Receptor 5 Product Portfolio Table 76. Aevi Genomic Medicine Inc Recent Development Table 77. Bristol-Myers Squibb Company Company Information Table 78. Bristol-Myers Squibb Company Business Overview Table 79. Bristol-Myers Squibb Company Metabotropic Glutamate Receptor 5 Sales (k units), Price (US$/unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 80. Bristol-Myers Squibb Company Metabotropic Glutamate Receptor 5 Product Portfolio Table 81. Bristol-Myers Squibb Company Recent Development Table 82. Heptares Therapeutics Ltd Company Information Table 83. Heptares Therapeutics Ltd Business Overview Table 84. Heptares Therapeutics Ltd Metabotropic Glutamate Receptor 5 Sales (k units), Price (US$/unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 85. Heptares Therapeutics Ltd Metabotropic Glutamate Receptor 5 Product Portfolio Table 86. Heptares Therapeutics Ltd Recent Development Table 87. Merz Pharma GmbH & Co KgaA Company Information Table 88. Merz Pharma GmbH & Co KgaA Business Overview Table 89. Merz Pharma GmbH & Co KgaA Metabotropic Glutamate Receptor 5 Sales (k units), Price (US$/unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 90. Merz Pharma GmbH & Co KgaA Metabotropic Glutamate Receptor 5 Product Portfolio Table 91. Merz Pharma GmbH & Co KgaA Recent Development Table 92. Richter Gedeon Nyrt Company Information Table 93. Richter Gedeon Nyrt Business Overview Table 94. Richter Gedeon Nyrt Metabotropic Glutamate Receptor 5 Sales (k units), Price (US$/unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 95. Richter Gedeon Nyrt Metabotropic Glutamate Receptor 5 Product Portfolio Table 96. Richter Gedeon Nyrt Recent Development Table 97. Sumitomo Dainippon Pharma Co Ltd Company Information Table 98. Sumitomo Dainippon Pharma Co Ltd Business Overview Table 99. Sumitomo Dainippon Pharma Co Ltd Metabotropic Glutamate Receptor 5 Sales (k units), Price (US$/unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 100. Sumitomo Dainippon Pharma Co Ltd Metabotropic Glutamate Receptor 5 Product Portfolio Table 101. Sumitomo Dainippon Pharma Co Ltd Recent Development Table 102. Toray Industries Inc Company Information Table 103. Toray Industries Inc Business Overview Table 104. Toray Industries Inc Metabotropic Glutamate Receptor 5 Sales (k units), Price (US$/unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 105. Toray Industries Inc Metabotropic Glutamate Receptor 5 Product Portfolio Table 106. Toray Industries Inc Recent Development Table 107. Eli Lilly and Company Company Information Table 108. Eli Lilly and Company Business Overview Table 109. Eli Lilly and Company Metabotropic Glutamate Receptor 5 Sales (k units), Price (US$/unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 110. Eli Lilly and Company Metabotropic Glutamate Receptor 5 Product Portfolio Table 111. Eli Lilly and Company Recent Development Table 112. Novartis AG Company Information Table 113. Novartis AG Business Overview Table 114. Novartis AG Metabotropic Glutamate Receptor 5 Sales (k units), Price (US$/unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 115. Novartis AG Metabotropic Glutamate Receptor 5 Product Portfolio Table 116. Novartis AG Recent Development Table 117. Johnson & Johnson Company Information Table 118. Johnson & Johnson Business Overview Table 119. Johnson & Johnson Metabotropic Glutamate Receptor 5 Sales (k units), Price (US$/unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 120. Johnson & Johnson Metabotropic Glutamate Receptor 5 Product Portfolio Table 121. Johnson & Johnson Recent Development Table 122. Eisai Co Ltd Company Information Table 123. Eisai Co Ltd Business Overview Table 124. Eisai Co Ltd Metabotropic Glutamate Receptor 5 Sales (k units), Price (US$/unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 125. Eisai Co Ltd Metabotropic Glutamate Receptor 5 Product Portfolio Table 126. Eisai Co Ltd Recent Development Table 127. Key Raw Materials Table 128. Raw Materials Key Suppliers Table 129. Metabotropic Glutamate Receptor 5 Distributors List Table 130. Metabotropic Glutamate Receptor 5 Customers List Table 131. Research Programs/Design for This Report Table 132. Authors List of This Report Table 133. Secondary Sources Table 134. Primary Sources List of Figures Figure 1. Metabotropic Glutamate Receptor 5 Product Image Figure 2. Global Metabotropic Glutamate Receptor 5 Market Size (US$ Million), 2021 VS 2025 VS 2032 Figure 3. Global Metabotropic Glutamate Receptor 5 Market Size (2021-2032) & (US$ Million) Figure 4. Global Metabotropic Glutamate Receptor 5 Sales (2021-2032) & (k units) Figure 5. Global Metabotropic Glutamate Receptor 5 Average Price (US$/unit) & (2021-2032) Figure 6. Global Top 5 and 10 Metabotropic Glutamate Receptor 5 Players Market Share by Revenue in 2025 Figure 7. Manufacturers Type (Tier 1, Tier 2, and Tier 3): 2021 VS 2025 Figure 8. Alloswitch-1 Image Figure 9. BMS-952048 Image Figure 10. BMS-955829 Image Figure 11. Dipraglurant ER Image Figure 12. Others Image Figure 13. Global Metabotropic Glutamate Receptor 5 Sales by Type (2021 VS 2025 VS 2032) & (k units) Figure 14. Global Metabotropic Glutamate Receptor 5 Sales Market Share 2021 VS 2025 VS 2032 Figure 15. Global Metabotropic Glutamate Receptor 5 Sales Market Share by Type (2021-2032) Figure 16. Global Metabotropic Glutamate Receptor 5 Revenue by Type (2021 VS 2025 VS 2032) & (k units) Figure 17. Global Metabotropic Glutamate Receptor 5 Revenue Market Share 2021 VS 2025 VS 2032 Figure 18. Global Metabotropic Glutamate Receptor 5 Revenue Market Share by Type (2021-2032) Figure 19. Major Depressive Disorder Image Figure 20. Alcohol Addiction Image Figure 21. Alzheimer's Disease Image Figure 22. Others Image Figure 23. Global Metabotropic Glutamate Receptor 5 Sales by Application (2021 VS 2025 VS 2032) & (k units) Figure 24. Global Metabotropic Glutamate Receptor 5 Sales Market Share 2021 VS 2025 VS 2032 Figure 25. Global Metabotropic Glutamate Receptor 5 Sales Market Share by Application (2021-2032) Figure 26. Global Metabotropic Glutamate Receptor 5 Revenue by Application (2021 VS 2025 VS 2032) & (k units) Figure 27. Global Metabotropic Glutamate Receptor 5 Revenue Market Share 2021 VS 2025 VS 2032 Figure 28. Global Metabotropic Glutamate Receptor 5 Revenue Market Share by Application (2021-2032) Figure 29. North America Metabotropic Glutamate Receptor 5 Sales and Growth Rate (2021-2032) & (k units) Figure 30. North America Metabotropic Glutamate Receptor 5 Sales Market Share by Country (2021-2032) Figure 31. U.S. Metabotropic Glutamate Receptor 5 Sales and Growth Rate (2021-2032) & (k units) Figure 32. Canada Metabotropic Glutamate Receptor 5 Sales and Growth Rate (2021-2032) & (k units) Figure 33. Mexico Metabotropic Glutamate Receptor 5 Sales and Growth Rate (2021-2032) & (k units) Figure 34. Europe Metabotropic Glutamate Receptor 5 Sales and Growth Rate (2021-2032) & (k units) Figure 35. Europe Metabotropic Glutamate Receptor 5 Sales Market Share by Country (2021-2032) Figure 36. Germany Metabotropic Glutamate Receptor 5 Sales and Growth Rate (2021-2032) & (k units) Figure 37. France Metabotropic Glutamate Receptor 5 Sales and Growth Rate (2021-2032) & (k units) Figure 38. U.K. Metabotropic Glutamate Receptor 5 Sales and Growth Rate (2021-2032) & (k units) Figure 39. Italy Metabotropic Glutamate Receptor 5 Sales and Growth Rate (2021-2032) & (k units) Figure 40. Netherlands Metabotropic Glutamate Receptor 5 Sales and Growth Rate (2021-2032) & (k units) Figure 41. Asia Pacific Metabotropic Glutamate Receptor 5 Sales and Growth Rate (2021-2032) & (k units) Figure 42. Asia Pacific Metabotropic Glutamate Receptor 5 Sales Market Share by Country (2021-2032) Figure 43. China Metabotropic Glutamate Receptor 5 Sales and Growth Rate (2021-2032) & (k units) Figure 44. Japan Metabotropic Glutamate Receptor 5 Sales and Growth Rate (2021-2032) & (k units) Figure 45. South Korea Metabotropic Glutamate Receptor 5 Sales and Growth Rate (2021-2032) & (k units) Figure 46. Southeast Asia Metabotropic Glutamate Receptor 5 Sales and Growth Rate (2021-2032) & (k units) Figure 47. India Metabotropic Glutamate Receptor 5 Sales and Growth Rate (2021-2032) & (k units) Figure 48. Australia Metabotropic Glutamate Receptor 5 Sales and Growth Rate (2021-2032) & (k units) Figure 49. South America, Middle East and Africa Metabotropic Glutamate Receptor 5 Sales and Growth Rate (2021-2032) & (k units) Figure 50. South America, Middle East and Africa Metabotropic Glutamate Receptor 5 Sales Market Share by Country (2021-2032) Figure 51. Brazil Metabotropic Glutamate Receptor 5 Sales and Growth Rate (2021-2032) & (k units) Figure 52. South Africa Metabotropic Glutamate Receptor 5 Sales and Growth Rate (2021-2032) & (k units) Figure 53. Saudi Arabia Metabotropic Glutamate Receptor 5 Sales and Growth Rate (2021-2032) & (k units) Figure 54. Turkey Metabotropic Glutamate Receptor 5 Sales and Growth Rate (2021-2032) & (k units) Figure 55. Argentina Metabotropic Glutamate Receptor 5 Sales and Growth Rate (2021-2032) & (k units) Figure 56. UAE Metabotropic Glutamate Receptor 5 Sales and Growth Rate (2021-2032) & (k units) Figure 57. Egypt Metabotropic Glutamate Receptor 5 Sales and Growth Rate (2021-2032) & (k units) Figure 58. Chile Metabotropic Glutamate Receptor 5 Sales and Growth Rate (2021-2032) & (k units) Figure 59. Global Metabotropic Glutamate Receptor 5 Revenue (CAGR) by Region: 2021 VS 2025 VS 2032 (US$ Million) Figure 60. Global Metabotropic Glutamate Receptor 5 Revenue Market Share by Region in Percentage: 2025 Versus 2032 Figure 61. North America Metabotropic Glutamate Receptor 5 Revenue (2021-2032) & (US$ Million) Figure 62. North America Metabotropic Glutamate Receptor 5 Revenue Share by Country: 2021 VS 2025 VS 2032 Figure 63. Europe Metabotropic Glutamate Receptor 5 Revenue (2021-2032) & (US$ Million) Figure 64. Europe Metabotropic Glutamate Receptor 5 Revenue Share by Country: 2021 VS 2025 VS 2032 Figure 65. Asia-Pacific Metabotropic Glutamate Receptor 5 Revenue (2021-2032) & (US$ Million) Figure 66. Asia-Pacific Metabotropic Glutamate Receptor 5 Revenue Share by Country: 2021 VS 2025 VS 2032 Figure 67. South America, Middle East and Africa Metabotropic Glutamate Receptor 5 Revenue (2021-2032) & (US$ Million) Figure 68. South America, Middle East and Africa Metabotropic Glutamate Receptor 5 Revenue Share by Country: 2021 VS 2025 VS 2032 Figure 69. Metabotropic Glutamate Receptor 5 Value Chain Figure 70. Manufacturing Cost Structure Figure 71. Metabotropic Glutamate Receptor 5 Production Mode & Process Figure 72. Direct Comparison with Distribution Share Figure 73. Distributors Profiles Figure 74. Years Considered Figure 75. Research Process Figure 76. Key Executives Interviewed

Scope & coverage.

Types
  • Alloswitch-1
  • BMS-952048
  • BMS-955829
  • Dipraglurant ER
  • Others
Applications
  • Major Depressive Disorder
  • Alcohol Addiction
  • Alzheimer's Disease
  • Others
Companies covered
  • Addex Therapeutics Ltd
  • Aevi Genomic Medicine Inc
  • Bristol-Myers Squibb Company
  • Heptares Therapeutics Ltd
  • Merz Pharma GmbH & Co KgaA
  • Richter Gedeon Nyrt
  • Sumitomo Dainippon Pharma Co Ltd
  • Toray Industries Inc
  • Eli Lilly and Company
  • Novartis AG
  • Johnson & Johnson
  • Eisai Co Ltd

Inside the report.

1 Market Overview
  1. 1.1 Product Definition
  2. 1.2 Global Metabotropic Glutamate Receptor 5 Market Size, 2021 VS 2025 VS 2032
  3. 1.3 Global Metabotropic Glutamate Receptor 5 Market Size Estimates and Forecasts (2021-2032)
  4. 1.4 Global Metabotropic Glutamate Receptor 5 Sales Estimates and Forecasts (2021-2032)
  5. 1.5 Global Metabotropic Glutamate Receptor 5 Market Average Price (2021-2032)
  6. 1.6 Assumptions and Limitations
  7. 1.7 Study Goals and Objectives
2 Global Metabotropic Glutamate Receptor 5 Market Dynamics
  1. 2.1 Metabotropic Glutamate Receptor 5 Industry Trends
  2. 2.2 Metabotropic Glutamate Receptor 5 Industry Drivers
  3. 2.3 Metabotropic Glutamate Receptor 5 Industry Opportunities and Challenges
  4. 2.4 Metabotropic Glutamate Receptor 5 Industry Restraints
3 Metabotropic Glutamate Receptor 5 Market by Manufacturers
  1. 3.1 Global Metabotropic Glutamate Receptor 5 Revenue by Manufacturers (2021-2026)
  2. 3.2 Global Metabotropic Glutamate Receptor 5 Sales by Manufacturers (2021-2026)
  3. 3.3 Global Metabotropic Glutamate Receptor 5 Average Sales Price by Manufacturers (2021-2026)
  4. 3.4 Global Metabotropic Glutamate Receptor 5 Industry Manufacturers Ranking, 2024 VS 2025 VS 2026
  5. 3.5 Global Metabotropic Glutamate Receptor 5 Key Manufacturers Manufacturing Sites & Headquarters
  6. 3.6 Global Metabotropic Glutamate Receptor 5 Manufacturers, Product Type & Application
  7. 3.7 Global Metabotropic Glutamate Receptor 5 Manufacturers Establishment Date
  8. 3.8 Market Competitive Analysis
  9. 3.8.1 Global Metabotropic Glutamate Receptor 5 Market CR5 and HHI
  10. 3.8.2 Global Top 5 and 10 Metabotropic Glutamate Receptor 5 Players Market Share by Revenue in 2025
  11. 3.8.3 2025 Metabotropic Glutamate Receptor 5 Tier 1, Tier 2, and Tier 3
4 Metabotropic Glutamate Receptor 5 Market by Type
  1. 4.1 Metabotropic Glutamate Receptor 5 Type Introduction
  2. 4.1.1 Alloswitch-1
  3. 4.1.2 BMS-952048
  4. 4.1.3 BMS-955829
  5. 4.1.4 Dipraglurant ER
  6. 4.1.5 Others
  7. 4.2 Global Metabotropic Glutamate Receptor 5 Sales by Type
  8. 4.2.1 Global Metabotropic Glutamate Receptor 5 Sales by Type (2021 VS 2025 VS 2032)
  9. 4.2.2 Global Metabotropic Glutamate Receptor 5 Sales by Type (2021-2032)
  10. 4.2.3 Global Metabotropic Glutamate Receptor 5 Sales Market Share by Type (2021-2032)
  11. 4.3 Global Metabotropic Glutamate Receptor 5 Revenue by Type
  12. 4.3.1 Global Metabotropic Glutamate Receptor 5 Revenue by Type (2021 VS 2025 VS 2032)
  13. 4.3.2 Global Metabotropic Glutamate Receptor 5 Revenue by Type (2021-2032)
  14. 4.3.3 Global Metabotropic Glutamate Receptor 5 Revenue Market Share by Type (2021-2032)
5 Metabotropic Glutamate Receptor 5 Market by Application
  1. 5.1 Metabotropic Glutamate Receptor 5 Application Introduction
  2. 5.1.1 Major Depressive Disorder
  3. 5.1.2 Alcohol Addiction
  4. 5.1.3 Alzheimer's Disease
  5. 5.1.4 Others
  6. 5.2 Global Metabotropic Glutamate Receptor 5 Sales by Application
  7. 5.2.1 Global Metabotropic Glutamate Receptor 5 Sales by Application (2021 VS 2025 VS 2032)
  8. 5.2.2 Global Metabotropic Glutamate Receptor 5 Sales by Application (2021-2032)
  9. 5.2.3 Global Metabotropic Glutamate Receptor 5 Sales Market Share by Application (2021-2032)
  10. 5.3 Global Metabotropic Glutamate Receptor 5 Revenue by Application
  11. 5.3.1 Global Metabotropic Glutamate Receptor 5 Revenue by Application (2021 VS 2025 VS 2032)
  12. 5.3.2 Global Metabotropic Glutamate Receptor 5 Revenue by Application (2021-2032)
  13. 5.3.3 Global Metabotropic Glutamate Receptor 5 Revenue Market Share by Application (2021-2032)
6 Global Metabotropic Glutamate Receptor 5 Sales by Region
  1. 6.1 Global Metabotropic Glutamate Receptor 5 Sales by Region: 2021 VS 2025 VS 2032
  2. 6.2 Global Metabotropic Glutamate Receptor 5 Sales by Region (2021-2032)
  3. 6.2.1 Global Metabotropic Glutamate Receptor 5 Sales by Region (2021-2026)
  4. 6.2.2 Global Metabotropic Glutamate Receptor 5 Sales Forecasted by Region (2027-2032)
  5. 6.3 North America
  6. 6.3.1 North America Metabotropic Glutamate Receptor 5 Sales Growth Rate by Country: 2021 VS 2025 VS 2032
  7. 6.3.2 North America Metabotropic Glutamate Receptor 5 Sales by Country (2021-2032)
  8. 6.3.3 U.S.
  9. 6.3.4 Canada
  10. 6.3.5 Mexico
  11. 6.4 Europe
  12. 6.4.1 Europe Metabotropic Glutamate Receptor 5 Sales Growth Rate by Country: 2021 VS 2025 VS 2032
  13. 6.4.2 Europe Metabotropic Glutamate Receptor 5 Sales by Country (2021-2032)
  14. 6.4.3 Germany
  15. 6.4.4 France
  16. 6.4.5 U.K.
  17. 6.4.6 Italy
  18. 6.4.7 Netherlands
  19. 6.5 Asia Pacific
  20. 6.5.1 Asia Pacific Metabotropic Glutamate Receptor 5 Sales Growth Rate by Country: 2021 VS 2025 VS 2032
  21. 6.5.2 Asia Pacific Metabotropic Glutamate Receptor 5 Sales by Country (2021-2032)
  22. 6.5.3 China
  23. 6.5.4 Japan
  24. 6.5.5 South Korea
  25. 6.5.6 Southeast Asia
  26. 6.5.7 India
  27. 6.5.8 Australia
  28. 6.6 South America, Middle East and Africa
  29. 6.6.1 South America, Middle East and Africa Metabotropic Glutamate Receptor 5 Sales Growth Rate by Country: 2021 VS 2025 VS 2032
  30. 6.6.2 South America, Middle East and Africa Metabotropic Glutamate Receptor 5 Sales by Country (2021-2032)
  31. 6.6.3 Brazil
  32. 6.6.4 South Africa
  33. 6.6.5 Saudi Arabia
  34. 6.6.6 Turkey
  35. 6.6.6 Argentina
  36. 6.6.6 UAE
  37. 6.6.6 Egypt
  38. 6.6.6 Chile
7 Global Metabotropic Glutamate Receptor 5 Revenue by Region
  1. 7.1 Global Metabotropic Glutamate Receptor 5 Revenue by Region
  2. 7.1.1 Global Metabotropic Glutamate Receptor 5 Revenue by Region: 2021 VS 2025 VS 2032
  3. 7.1.2 Global Metabotropic Glutamate Receptor 5 Revenue by Region (2021-2026)
  4. 7.1.3 Global Metabotropic Glutamate Receptor 5 Revenue by Region (2027-2032)
  5. 7.1.4 Global Metabotropic Glutamate Receptor 5 Revenue Market Share by Region (2021-2032)
  6. 7.2 North America
  7. 7.2.1 North America Metabotropic Glutamate Receptor 5 Revenue (2021-2032)
  8. 7.2.2 North America Metabotropic Glutamate Receptor 5 Revenue Share by Country: 2021 VS 2025 VS 2032
  9. 7.3 Europe
  10. 7.3.1 Europe Metabotropic Glutamate Receptor 5 Revenue (2021-2032)
  11. 7.3.2 Europe Metabotropic Glutamate Receptor 5 Revenue Share by Country: 2021 VS 2025 VS 2032
  12. 7.4 Asia-Pacific
  13. 7.4.1 Asia-Pacific Metabotropic Glutamate Receptor 5 Revenue (2021-2032)
  14. 7.4.2 Asia-Pacific Metabotropic Glutamate Receptor 5 Revenue Share by Country: 2021 VS 2025 VS 2032
  15. 7.5 South America, Middle East and Africa
  16. 7.5.1 South America, Middle East and Africa Metabotropic Glutamate Receptor 5 Revenue (2021-2032)
  17. 7.5.2 South America, Middle East and Africa Metabotropic Glutamate Receptor 5 Revenue Share by Country: 2021 VS 2025 VS 2032
8 Company Profiles
  1. 8.1 Addex Therapeutics Ltd
  2. 8.1.1 Addex Therapeutics Ltd Company Information
  3. 8.1.2 Addex Therapeutics Ltd Business Overview
  4. 8.1.3 Addex Therapeutics Ltd Metabotropic Glutamate Receptor 5 Sales, Price, Revenue and Gross Margin (2021-2026)
  5. 8.1.4 Addex Therapeutics Ltd Metabotropic Glutamate Receptor 5 Product Portfolio
  6. 8.1.5 Addex Therapeutics Ltd Recent Developments
  7. 8.2 Aevi Genomic Medicine Inc
  8. 8.2.1 Aevi Genomic Medicine Inc Company Information
  9. 8.2.2 Aevi Genomic Medicine Inc Business Overview
  10. 8.2.3 Aevi Genomic Medicine Inc Metabotropic Glutamate Receptor 5 Sales, Price, Revenue and Gross Margin (2021-2026)
  11. 8.2.4 Aevi Genomic Medicine Inc Metabotropic Glutamate Receptor 5 Product Portfolio
  12. 8.2.5 Aevi Genomic Medicine Inc Recent Developments
  13. 8.3 Bristol-Myers Squibb Company
  14. 8.3.1 Bristol-Myers Squibb Company Company Information
  15. 8.3.2 Bristol-Myers Squibb Company Business Overview
  16. 8.3.3 Bristol-Myers Squibb Company Metabotropic Glutamate Receptor 5 Sales, Price, Revenue and Gross Margin (2021-2026)
  17. 8.3.4 Bristol-Myers Squibb Company Metabotropic Glutamate Receptor 5 Product Portfolio
  18. 8.3.5 Bristol-Myers Squibb Company Recent Developments
  19. 8.4 Heptares Therapeutics Ltd
  20. 8.4.1 Heptares Therapeutics Ltd Company Information
  21. 8.4.2 Heptares Therapeutics Ltd Business Overview
  22. 8.4.3 Heptares Therapeutics Ltd Metabotropic Glutamate Receptor 5 Sales, Price, Revenue and Gross Margin (2021-2026)
  23. 8.4.4 Heptares Therapeutics Ltd Metabotropic Glutamate Receptor 5 Product Portfolio
  24. 8.4.5 Heptares Therapeutics Ltd Recent Developments
  25. 8.5 Merz Pharma GmbH & Co KgaA
  26. 8.5.1 Merz Pharma GmbH & Co KgaA Company Information
  27. 8.5.2 Merz Pharma GmbH & Co KgaA Business Overview
  28. 8.5.3 Merz Pharma GmbH & Co KgaA Metabotropic Glutamate Receptor 5 Sales, Price, Revenue and Gross Margin (2021-2026)
  29. 8.5.4 Merz Pharma GmbH & Co KgaA Metabotropic Glutamate Receptor 5 Product Portfolio
  30. 8.5.5 Merz Pharma GmbH & Co KgaA Recent Developments
  31. 8.6 Richter Gedeon Nyrt
  32. 8.6.1 Richter Gedeon Nyrt Company Information
  33. 8.6.2 Richter Gedeon Nyrt Business Overview
  34. 8.6.3 Richter Gedeon Nyrt Metabotropic Glutamate Receptor 5 Sales, Price, Revenue and Gross Margin (2021-2026)
  35. 8.6.4 Richter Gedeon Nyrt Metabotropic Glutamate Receptor 5 Product Portfolio
  36. 8.6.5 Richter Gedeon Nyrt Recent Developments
  37. 8.7 Sumitomo Dainippon Pharma Co Ltd
  38. 8.7.1 Sumitomo Dainippon Pharma Co Ltd Company Information
  39. 8.7.2 Sumitomo Dainippon Pharma Co Ltd Business Overview
  40. 8.7.3 Sumitomo Dainippon Pharma Co Ltd Metabotropic Glutamate Receptor 5 Sales, Price, Revenue and Gross Margin (2021-2026)
  41. 8.7.4 Sumitomo Dainippon Pharma Co Ltd Metabotropic Glutamate Receptor 5 Product Portfolio
  42. 8.7.5 Sumitomo Dainippon Pharma Co Ltd Recent Developments
  43. 8.8 Toray Industries Inc
  44. 8.8.1 Toray Industries Inc Company Information
  45. 8.8.2 Toray Industries Inc Business Overview
  46. 8.8.3 Toray Industries Inc Metabotropic Glutamate Receptor 5 Sales, Price, Revenue and Gross Margin (2021-2026)
  47. 8.8.4 Toray Industries Inc Metabotropic Glutamate Receptor 5 Product Portfolio
  48. 8.8.5 Toray Industries Inc Recent Developments
  49. 8.9 Eli Lilly and Company
  50. 8.9.1 Eli Lilly and Company Company Information
  51. 8.9.2 Eli Lilly and Company Business Overview
  52. 8.9.3 Eli Lilly and Company Metabotropic Glutamate Receptor 5 Sales, Price, Revenue and Gross Margin (2021-2026)
  53. 8.9.4 Eli Lilly and Company Metabotropic Glutamate Receptor 5 Product Portfolio
  54. 8.9.5 Eli Lilly and Company Recent Developments
  55. 8.10 Novartis AG
  56. 8.10.1 Novartis AG Company Information
  57. 8.10.2 Novartis AG Business Overview
  58. 8.10.3 Novartis AG Metabotropic Glutamate Receptor 5 Sales, Price, Revenue and Gross Margin (2021-2026)
  59. 8.10.4 Novartis AG Metabotropic Glutamate Receptor 5 Product Portfolio
  60. 8.10.5 Novartis AG Recent Developments
  61. 8.11 Johnson & Johnson
  62. 8.11.1 Johnson & Johnson Company Information
  63. 8.11.2 Johnson & Johnson Business Overview
  64. 8.11.3 Johnson & Johnson Metabotropic Glutamate Receptor 5 Sales, Price, Revenue and Gross Margin (2021-2026)
  65. 8.11.4 Johnson & Johnson Metabotropic Glutamate Receptor 5 Product Portfolio
  66. 8.11.5 Johnson & Johnson Recent Developments
  67. 8.12 Eisai Co Ltd
  68. 8.12.1 Eisai Co Ltd Company Information
  69. 8.12.2 Eisai Co Ltd Business Overview
  70. 8.12.3 Eisai Co Ltd Metabotropic Glutamate Receptor 5 Sales, Price, Revenue and Gross Margin (2021-2026)
  71. 8.12.4 Eisai Co Ltd Metabotropic Glutamate Receptor 5 Product Portfolio
  72. 8.12.5 Eisai Co Ltd Recent Developments
9 Value Chain and Sales Channels Analysis
  1. 9.1 Metabotropic Glutamate Receptor 5 Value Chain Analysis
  2. 9.1.1 Metabotropic Glutamate Receptor 5 Key Raw Materials
  3. 9.1.2 Raw Materials Key Suppliers
  4. 9.1.3 Manufacturing Cost Structure
  5. 9.1.4 Metabotropic Glutamate Receptor 5 Production Mode & Process
  6. 9.2 Metabotropic Glutamate Receptor 5 Sales Channels Analysis
  7. 9.2.1 Direct Comparison with Distribution Share
  8. 9.2.2 Metabotropic Glutamate Receptor 5 Distributors
  9. 9.2.3 Metabotropic Glutamate Receptor 5 Customers
10 Concluding Insights
    11 Appendix
    1. 11.1 Reasons for Doing This Study
    2. 11.2 Research Methodology
    3. 11.3 Research Process
    4. 11.4 Authors List of This Report
    5. 11.5 Data Source
    6. 11.5.1 Secondary Sources
    7. 11.5.2 Primary Sources
    8. 11.6 Disclaimer

    GET THE RESEARCH

    Choose your license.

    Choose who needs access.
    All options are for this report and research series.

    Compare access permissions.

    Single User License
    One named user. Individual access.
    Multi User License
    Up to 5 users in the same department.
    Enterprise License
    Organization-wide access within the agreed license.

    Access applies to the purchased edition. Later editions are separate purchases.

    License options
    $3,950USD
    Buy now

    PDF by email within 3–5 working days after payment confirmation.

    Talk to an analyst
    APO Research
    Talk to an analyst